Establishment Labs Holdings, Inc. (ESTA)
68.36
-0.60
(-0.88%)
USD |
NASDAQ |
Oct 29, 16:00
68.41
+0.05
(+0.07%)
After-Hours: 16:46
Establishment Labs Holdings Enterprise Value : 2.247B for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 2.247B |
| October 27, 2026 | 2.187B |
| October 26, 2026 | 2.152B |
| October 23, 2026 | 2.093B |
| October 22, 2026 | 2.085B |
| October 21, 2026 | 2.048B |
| October 20, 2026 | 2.012B |
| October 19, 2026 | 1.928B |
| October 16, 2026 | 1.956B |
| October 15, 2026 | 2.021B |
| October 14, 2026 | 1.917B |
| October 13, 2026 | 1.934B |
| October 12, 2026 | 2.029B |
| October 09, 2026 | 2.030B |
| October 08, 2026 | 1.998B |
| October 07, 2026 | 2.095B |
| October 06, 2026 | 2.138B |
| October 05, 2026 | 2.173B |
| October 02, 2026 | 2.101B |
| October 01, 2026 | 2.071B |
| September 30, 2026 | 2.104B |
| September 29, 2026 | 2.090B |
| September 28, 2026 | 2.139B |
| September 25, 2026 | 2.158B |
| September 24, 2026 | 2.146B |
| Date | Value |
|---|---|
| September 23, 2026 | 2.211B |
| September 22, 2026 | 2.285B |
| September 21, 2026 | 2.211B |
| September 18, 2026 | 2.257B |
| September 17, 2026 | 2.265B |
| September 16, 2026 | 2.313B |
| September 15, 2026 | 2.322B |
| September 14, 2026 | 2.335B |
| September 11, 2026 | 2.306B |
| September 10, 2026 | 2.319B |
| September 09, 2026 | 2.412B |
| September 08, 2026 | 2.436B |
| September 04, 2026 | 2.406B |
| September 03, 2026 | 2.347B |
| September 02, 2026 | 2.425B |
| September 01, 2026 | 2.265B |
| August 31, 2026 | 2.258B |
| August 28, 2026 | 2.297B |
| August 27, 2026 | 2.332B |
| August 26, 2026 | 2.351B |
| August 25, 2026 | 2.342B |
| August 24, 2026 | 2.339B |
| August 21, 2026 | 2.358B |
| August 20, 2026 | 2.323B |
| August 19, 2026 | 2.438B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 205.26B |
| AngioDynamics, Inc. | 491.37M |
| Alphatec Holdings, Inc. | 2.257B |
| AtriCure, Inc. | 3.030B |
| Baxter International, Inc. | 19.84B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.75M |
| Revenue (Quarterly) | 67.54M |
| Total Expenses (Quarterly) | 79.29M |
| EPS Diluted (Quarterly) | -0.39 |
| Gross Profit Margin (Quarterly) | 70.64% |
| Profit Margin (Quarterly) | -17.39% |
| Earnings Yield | -1.90% |
| Normalized Earnings Yield | -1.903 |